ELEVATED IMMUNOREACTIVE ENDOTHELIN-1 LEVELS IN NEWBORN-INFANTS WITH PERSISTENT PULMONARY-HYPERTENSION
ELEVATED IMMUNOREACTIVE ENDOTHELIN-1 LEVELS IN NEWBORN-INFANTS WITH PERSISTENT PULMONARY-HYPERTENSION
复制标题
DOI:
10.1016/s0022-3476(05)81552-5
复制
发表时间:
1993-07-01
影响因子:
5.1
通讯作者:
ABMAN, SH
中科院分区:
文献类型:
--
作者:
ROSENBERG, AA;KENNAUGH, J;ABMAN, SH
To study the potential role of endothelin-1, a potent endothelium-derived vasoconstrictor peptide, in the pathophysiology of persistent pulmonary hypertension of the newborn (PPHN), we measured arterial concentrations of immunoreactive endothelin-1 (irET-1) in 24 neonates with PPHN. Secondary diagnoses included meconium aspiration syndrome (13 patients), sepsis (2), congenital diaphragmatic hernia (1), asphyxia (1), pulmonary hemorrhage (1), aspiration of blood (1), and respiratory distress syndrome (1). Compared with irET-1 levels in umbilical cord blood in normal infants (15.1 +/- 4.1 pg/ml; mean +/- SEM) and in newborn infants with hyaline membrane disease who were supported by mechanical ventilation (11.8 +/- 1.2 pg/ml), infants with PPHN had markedly elevated circulating irET-1 levels (27.6 +/- 3.6 pg/ml; p